ArticleJournal of psychopharmacology (Oxford, England)2022
Can cannabis kill? Characteristics of deaths following cannabis use in England (1998-2020).
Article in Journal of psychopharmacology (Oxford, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.
- Deaths related to the use of diarylethylamines, with a focus on the United Kingdom: A systematic review and case series report.Journal of psychopharmacology (Oxford, England) · 2026Pooled it
- Cannabis use and beliefs among people in recovery from substance use disorders.Journal of cannabis research · 2026Article
- Operationalizing ASSIST-based indicators to estimate the prevalence and correlates of problematic cannabis involvement among U.S. college students.Journal of cannabis research · 2026Article
- Drug poisonings following bariatric surgery: Case series report.British journal of clinical pharmacology · 2026Article
- 4F-MDMB-BICA toxicity: a fatal case and literature review of synthetic cannabinoid fatalities.Forensic science, medicine, and pathology · 2026Review
- Deaths following illicit ketamine use in England, Wales and Northern Ireland 1999-2024: An update report to inform the reclassification debate.Journal of psychopharmacology (Oxford, England) · 2026Article
- Cannabis Use and Analgesic Prescribing in UK Primary Care: A Retrospective Cohort Study of Patients with Osteoarthritis.Medicines (Basel, Switzerland) · 2025Article
- Fatal drug overdoses in healthcare workers: A thematic framework analysis of coroner reports.Addiction (Abingdon, England) · 2025Article
- Infant Death due to Cannabis Ingestion.Drug testing and analysis · 2025Article
- Prevalence and trends in cannabis use disorder and cannabis poisoning among Medicaid enrollees: a multistate analysis, 2011-2022.Health affairs scholar · 2025Article
- A Meta-Narrative Review of Channelopathies and Cannabis: Mechanistic, Epidemiologic, and Forensic Insights into Arrhythmia and Sudden Cardiac Death.International journal of molecular sciences · 2025Review
- Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits.European archives of psychiatry and clinical neuroscience · 2025Review
- Emergency Department Patients Presenting after Oral versus Inhaled Cannabinoid use: A Retrospective Analysis.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2025Article
- A qualitative content analysis of cannabis-related discussions on Reddit during the COVID-19 pandemic.PloS one · 2024Article
- Review
- The challenging issue of polydrug consumption: new trends of a deep-seated public health threat.Acta bio-medica : Atenei Parmensis · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCannabis is the most widely used illegal drug but is rarely considered a causal factor in death.
aimsThis study aimed to understand trends in deaths in England where cannabinoids were detected at post-mortem, and to evaluate the clinical utility of post-mortem cannabinoid concentrations in coronial investigations.
methodsDeaths with cannabinoid detections reported to the National Programme on Substance Abuse Deaths (NPSAD) were extracted and analysed.
resultsFrom 1998 to 2011, on average 7% of all cases reported to NPSAD had a cannabinoid detected (
conclusionsRisk of death due to cannabis toxicity is negligible. However, cannabis can prove fatal in circumstances with risk of traumatic physical injury, or in individuals with cardiac pathophysiologies. These indirect harms need careful consideration and further study to better elucidate the role cannabis plays in drug-related mortality. Furthermore, the relevance of cannabinoid quantifications in determining cause of death in coronial investigations is limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.